Where is SquareMind headquartered?

SquareMind is headquartered in Paris, France. The company has a team of 11-50 people.

What does SquareMind do?

SquareMind operates in the AI in Healthcare sector. SquareMind builds Swan, the world's first robot for full-body dermoscopy, automating standardized skin imaging paired with AI for change detection. Automates and standardizes full-body dermoscopic skin exams in minutes, making high-quality dermatology screening more efficient and accessible while keeping final clinical decisions with physicians.

When was SquareMind founded?

SquareMind was founded in 2019. It is based in Paris, France.

Who is the CEO of SquareMind?

Ali Khachlouf is the CEO of SquareMind. The company was founded in 2019.

Where is SquareMind located?

SquareMind is headquartered in Paris, France.

What funding stage is SquareMind at?

SquareMind is currently at the Active stage.

How many employees does SquareMind have?

SquareMind has approximately 11-50 employees.

SquareMind

Category: AI in Healthcare

SquareMind builds Swan, the world's first robot for full-body dermoscopy, automating standardized skin imaging paired with AI for change detection. SquareMind was founded in 2019. The company is led by Ali Khachlouf. Based in Paris, France. Team size: 11-50. Total funding raised: $18M. Latest round: Series A. Key investors include Sonder Capital, Bpifrance (Deeptech 2030 Fund), Adamed Technology, Calm/Storm Ventures, Teampact Ventures.

Founded: 2019
Headquarters: Paris, France
Team size: 11-50
Total funding: $18M

Value proposition

Automates and standardizes full-body dermoscopic skin exams in minutes, making high-quality dermatology screening more efficient and accessible while keeping final clinical decisions with physicians.

Products and solutions

Swan — a robotic-arm platform that captures full-body dermoscopic (magnified) skin images, paired with AI software for mole/lesion mapping and change detection over time

Unique value

Only platform combining full-body coverage AND dermoscopic-level image resolution in a fully automated robotic exam, versus competitors that offer one or the other

Target customer

Dermatology practices, hospitals, and healthcare providers

Industries served

Healthcare, Dermatology, Medical Robotics, Skin Cancer Screening

Technology advantage

Proprietary robotics engineering combined with AI-based dermoscopic image analysis and change-detection software; physician-in-the-loop clinical workflow design

How they differentiate

Swan is positioned as the first robot to combine full-body coverage with true dermoscopic resolution, whereas rivals like Canfield's VECTRA offer 3D full-body mapping without dermoscopic detail, and DermaSensor offers handheld point-of-care screening rather than full-body automated imaging

Main competitors

Canfield Scientific (VECTRA WB360), DermaSensor, Neko Health, 3Derm

Major milestones

Founded 2019 by Ali Khachlouf and Tanguy Serrat in Paris, developed Swan, the first robotic full-body dermoscopy platform, raised $18M (April 2026) led by Sonder Capital (Fred Moll, Intuitive Surgical founder) to commercialize Swan and launch in the US and European markets

Market positioning

Premium clinical-grade automated skin-imaging platform for hospitals and dermatology practices, expanding from France/Europe into the US market

Geographic focus

Europe (France) expanding into the United States

About Ali Khachlouf

Ex-Entrepreneur First (venture builder program), Oliver Wyman consultant, DTZ Asset Management; M.S. in General Engineering, CentraleSupélec (exchange at ESCP Business School London).

Latest news about SquareMind

SquareMind raises $18M for AI skin imaging robot Swan, targets US and Europe

More AI in Healthcare companies

Official website: https://www.squaremind.com